Serum calpain-5 as a biomarker for disease severity and clinical outcomes in COVID-19 patients

BMC Infectious Diseases · Published 2026-07-31 · DOI 10.1186/s12879-026-14115-7

Free full text

Authors (10)

Hai-Long Miao, Meng-Xue Liu, Wei Cao, Guo-Qiang Wu, Luo Li, Xiang Cai, Si-Han Wang, Lin Fu, Jun Fei, Fang Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Miao, H., Liu, M., Cao, W., et al. (2026). Serum calpain-5 as a biomarker for disease severity and clinical outcomes in COVID-19 patients. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14115-7

Related articles